Jefferies Financial Group’s Neumora Therapeutics NMRA Stock Holding History

Jefferies Financial Group’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64.4K	Sell	33,044 -11,226	-25%	-$29.1K	﹤0.01%	1632
2025 Q4	$79.2K	Sell	44,270 -2,330	-5%	-$5.1K	﹤0.01%	1727
2025 Q3	$84.8K	Buy	+46,600	New	+$75.3K	﹤0.01%	1355
2025 Q1	–	Sell	-10,000	Closed	-$106K	–	1875
2024 Q4	$106K	Buy	+10,000	New	+$120K	﹤0.01%	1453
2024 Q3	–	Sell	-32,500	Closed	-$319K	–	1658
2024 Q2	$319K	Buy	+32,500	New	+$336K	﹤0.01%	1103

Other funds holding NMRA

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return

Jefferies Financial Group's NMRA Position: Q1 2026 in Review

Jefferies Financial Group reduced its Neumora Therapeutics (NMRA) stake by 25% in Q1 2026, selling an estimated $29.1K and leaving 33,044 shares worth $64.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

Jefferies Financial Group first reported a position in NMRA in Q2 2024 and has held it in 5 quarters since. The position peaked at $319K in Q2 2024. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

Jefferies Financial Group held 33,044 shares of Neumora Therapeutics worth $64.4K as of Q1 2026.
Jefferies Financial Group sold 11,226 Neumora Therapeutics shares in Q1 2026, an estimated $29.1K.
Neumora Therapeutics made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1632 holding.
Jefferies Financial Group first reported a position in Neumora Therapeutics in Q2 2024 and has held it in 5 quarters since.
Jefferies Financial Group's Neumora Therapeutics position peaked at $319K in Q2 2024.
114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.